Results 91 to 100 of about 6,978 (279)

FARABİ'DE BAZI TEMEL KAVRAMLAR ÜZERİNE

open access: yesFelsefe Dünyası, 2008
Eyüp ŞAHİN, "FARABİ'DE BAZI TEMEL KAVRAMLAR ÜZERİNE", FELSEFE DÜNYASI DERGİSİ, SAYI ...
Eyüp Şahin
doaj  

A humidity resistant radon source developed by ion exchange of radium in a membrane

open access: yesRadiation Medicine and Protection
Objective: To develop a humidity resistant radon source on a membrane based on the ion exchange technique. Methods: 226Ra in its standard solution was adsorbed in the HP membrane through cation exchange.
Yanliang Chen, Linfeng He, Gang Han
doaj   +1 more source

FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee   +7 more
wiley   +1 more source

Batalyevsî’de sudur tasavvuru

open access: yesİslami İlimler Dergisi, 2012
Tanrı-âlem ilişkisini açıklamak üzere felsefe tarihinde farklı görüşler öne sürülse de klasik dönemde öne çıkan en önemli varsayım sudûr teorisi olmuştur.
Cahid Şenel
doaj  

Clinical Validation of Plasma p‐217tau in Neurological Diseases

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi   +13 more
wiley   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy